|
Post by od on Oct 11, 2015 21:54:08 GMT -5
Apologies savzak, my mistake. Should be "...the final price to patient cannot me LESS than price government pays...". Ok...back to my original question...why would the government refuse patients the ability to take advantage of such discounts when the government does not have to pay for it? I am not sure this link reflects current regulations - www.hg.org/article.asp?id=20235. It leads with "Federal law proscribes that drug manufacturers pay rebates to the states to insure that the Medicaid program is receiving the best price on covered drugs. When manufacturers determine the best price, they must include cash discounts, free goods, volume discounts, and rebates given on the covered drug."
|
|
|
Post by liane on Oct 12, 2015 3:59:08 GMT -5
savzak, The government negotiates their own discount price with the pharma companies, so they don't allow a further discount on top of that. This is not just for Afrezza. Liane, please help me understand...what does the government care if the patient gets an additional discount so long as the government doesn't have to pay for it? I'm assuming that it's actually Sanofi who won't provide the discount if the patient has other coverage. That would make sense. But the government refusing additional discounts SNY is offering doesn't make sense. I'm not saying it makes sense, but I have encountered it with other drug discount cards. I think "od" explained it as best I understand it.
|
|
|
Post by uvula on Oct 12, 2015 5:02:29 GMT -5
Just a guess but it could be sny and not the government that is not letting medicare patients use the discount card. Sny might end up losing money on each patient.
|
|
|
Post by beardawg on Oct 12, 2015 15:47:44 GMT -5
Ok...back to my original question...why would the government refuse patients the ability to take advantage of such discounts when the government does not have to pay for it? I am not sure this link reflects current regulations - www.hg.org/article.asp?id=20235. It leads with "Federal law proscribes that drug manufacturers pay rebates to the states to insure that the Medicaid program is receiving the best price on covered drugs. When manufacturers determine the best price, they must include cash discounts, free goods, volume discounts, and rebates given on the covered drug." That makes sense because the government wants to get that discount, not let the patient get it. If a company offers an additional discount, it means that the original discount given to the government wasn't the best discount.
|
|
|
Post by docfrezza on Nov 5, 2015 12:27:26 GMT -5
I found out some new information today. This is not related to me prescribing Afrezza to patients, it should go without saying that I am doing that. What I thought each of you would find interesting is that the Toujeo/Afrezza representatives are in Las Vegas right now and are coming home later today. The pure Afrezza representatives are not there, they were there a few weeks ago. While in Vegas the representatives are getting new training specifically on Afrezza. I do not know the details of this new training. The question I would ask each of you to ask yourself is why would Sanofi be doing Afrezza specific training at this point in time if they are planning on cutting ties with Mannkind in the foreseeable future. I just can't see that happening based upon the information that I was given earlier today. I was also told that the representatives are going to get some updated training on the pulmonary function studies in the next few weeks. I do not know the details regarding that at this time. Anyway, I thought that most of you would find this information to be enlightening. I wish I had more details but do not. The information that I have been given would tell me that Sanofi at least for the foreseeable future is planning to continue promoting Afrezza. The rumors are that the TV ads will start early next year but this is nothing more than a rumor from the representatives. We shall see.
|
|
|
Post by kball on Nov 5, 2015 12:38:27 GMT -5
I found out some new information today. This is not related to me prescribing Afrezza to patients, it should go without saying that I am doing that. What I thought each of you would find interesting is that the Toujeo/Afrezza representatives are in Las Vegas right now and are coming home later today. The pure Afrezza representatives are not there, they were there a few weeks ago. While in Vegas the representatives are getting new training specifically on Afrezza. I do not know the details of this new training. The question I would ask each of you to ask yourself is why would Sanofi be doing Afrezza specific training at this point in time if they are planning on cutting ties with Mannkind in the foreseeable future. I just can't see that happening based upon the information that I was given earlier today. I was also told that the representatives are going to get some updated training on the pulmonary function studies in the next few weeks. I do not know the details regarding that at this time. Anyway, I thought that most of you would find this information to be enlightening. I wish I had more details but do not. The information that I have been given would tell me that Sanofi at least for the foreseeable future is planning to continue promoting Afrezza. The rumors are that the TV ads will start early next year but this is nothing more than a rumor from the representatives. We shall see. Really appreciating your posts here Doc. Always informative
|
|
|
Post by roseylv on Nov 5, 2015 13:05:42 GMT -5
I found out some new information today. This is not related to me prescribing Afrezza to patients, it should go without saying that I am doing that. What I thought each of you would find interesting is that the Toujeo/Afrezza representatives are in Las Vegas right now and are coming home later today. The pure Afrezza representatives are not there, they were there a few weeks ago. While in Vegas the representatives are getting new training specifically on Afrezza. I do not know the details of this new training. The question I would ask each of you to ask yourself is why would Sanofi be doing Afrezza specific training at this point in time if they are planning on cutting ties with Mannkind in the foreseeable future. I just can't see that happening based upon the information that I was given earlier today. I was also told that the representatives are going to get some updated training on the pulmonary function studies in the next few weeks. I do not know the details regarding that at this time. Anyway, I thought that most of you would find this information to be enlightening. I wish I had more details but do not. The information that I have been given would tell me that Sanofi at least for the foreseeable future is planning to continue promoting Afrezza. The rumors are that the TV ads will start early next year but this is nothing more than a rumor from the representatives. We shall see. Thanks Docfrezz, We Appreciate your real world insight. I find it interesting that there was at least banter / rumors about the September vegas meeting and yet nobody has said boo about this meeting a few weeks back (insight coming from your rep). Perhaps things are getting more tightlipped and or secretive. Not sure if that is bad thing or good thing? Thanks again and keep the info flowing!
|
|
|
Post by rrtzmd on Nov 5, 2015 13:16:05 GMT -5
I found out some new information today. This is not related to me prescribing Afrezza to patients, it should go without saying that I am doing that. What I thought each of you would find interesting is that the Toujeo/Afrezza representatives are in Las Vegas right now and are coming home later today. The pure Afrezza representatives are not there, they were there a few weeks ago. While in Vegas the representatives are getting new training specifically on Afrezza. I do not know the details of this new training. The question I would ask each of you to ask yourself is why would Sanofi be doing Afrezza specific training at this point in time if they are planning on cutting ties with Mannkind in the foreseeable future. I just can't see that happening based upon the information that I was given earlier today. I was also told that the representatives are going to get some updated training on the pulmonary function studies in the next few weeks. I do not know the details regarding that at this time. Anyway, I thought that most of you would find this information to be enlightening. I wish I had more details but do not. The information that I have been given would tell me that Sanofi at least for the foreseeable future is planning to continue promoting Afrezza. The rumors are that the TV ads will start early next year but this is nothing more than a rumor from the representatives. We shall see. Apologies for going OT, but only for a second! I was just wondering if you could clear up a question causing some confusion elsewhere -- am I correct in assuming that you are not the "drfrezza" that posts on the Yahoo message board? Thanks.
|
|
|
Post by lakers on Nov 5, 2015 13:24:05 GMT -5
Here is the public domain corroboration.
Sanofi Breakthrough 2.0 - MGM Las Vegas I spoke to Matt last week (Wed 9/16/15), and he confirmed that SNY was having training in Vegas this week. He is currently in Europe at the EASD. Will be back on the 25th. It is my understanding that the SNY reps that call on GP's will be having their own training soon. I believe that David Kliff was spreading FUD claiming that 2/3 of the reps that were training this week were being asked not to attend. SNY made a decision to have the GP reps, the 2/3 in question (700) have training at their own meeting, since they already had a meeting coming up.
mnkd.proboardsDOTcom/user/336/recent#ixzz3m2XMiwLU By obamayoumama For those who were at BT 2.0, remember the first All-hand session and motto "Train the Trainers".
IMHO, Docfrezza's info has been highly accurate. He also posted on YMB under the same pen name.
BTW, Here is the mock Flop card: Sny to renew their effort on Label Improvement, Sales, and Marketing Afrezza together w/ Toujeo (cross-selling to Endos and PCPs).
Don't miss Sny Meet Mgmt tonight Thurs 11/5, 11:30 P PST, 8:30 CET Fri 11/6.
|
|
|
Post by docfrezza on Nov 5, 2015 13:47:52 GMT -5
I am NOT the drfrezza on YMB. My name there is also docfrezza. I have not posted there recently. This message board is a much friendlier place to post my information.
|
|
|
Post by vissertrades on Nov 5, 2015 14:04:10 GMT -5
Go AWAY!!!! Just Kidding, everyones on edge. We have a seemingly great drug that actually helps people control their diabetes in a meaniningful way but wall streeters just want to kill this (our) company. There is a major dissconect here!
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Nov 5, 2015 14:15:01 GMT -5
I am NOT the drfrezza on YMB. My name there is also docfrezza. I have not posted there recently. This message board is a much friendlier place to post my information. Appreciate the info doc. You are GP / Primary Care? I wonder if reps with Toujeo & Afrezza make a play for any pump patients. Way less expensive for insurance co, one daily injection of basal is a whole lot easier and more time efficient than playing around with a pump and infusion sets. Without the pump, patient can use the new Dexcom G5 sensor to send data right to the patients smartphone. No more bulky receiver needed, no more pump or 42" of infusion set tubing. www.dexcom.com/g5-mobile-cgm
|
|
|
Post by spinaltiger on Nov 5, 2015 14:19:42 GMT -5
Revealing your identity as one of the docs prescribing Afrezza would GREATLY improve your credibility. You have to understand, it is very difficult to assign a reliability factor to your posts since there is no way of knowing what you are saying is true.
|
|
|
Post by jimo on Nov 5, 2015 14:22:33 GMT -5
Spins - we're all mainly anonymous so take it for what it is. DocF is very credible for an anonymous contributor so leave it be as we want him coming back.
|
|
|
Post by hammer on Nov 5, 2015 14:40:31 GMT -5
I found out some new information today. This is not related to me prescribing Afrezza to patients, it should go without saying that I am doing that. What I thought each of you would find interesting is that the Toujeo/Afrezza representatives are in Las Vegas right now and are coming home later today. The pure Afrezza representatives are not there, they were there a few weeks ago. While in Vegas the representatives are getting new training specifically on Afrezza. I do not know the details of this new training. The question I would ask each of you to ask yourself is why would Sanofi be doing Afrezza specific training at this point in time if they are planning on cutting ties with Mannkind in the foreseeable future. I just can't see that happening based upon the information that I was given earlier today. I was also told that the representatives are going to get some updated training on the pulmonary function studies in the next few weeks. I do not know the details regarding that at this time. Anyway, I thought that most of you would find this information to be enlightening. I wish I had more details but do not. The information that I have been given would tell me that Sanofi at least for the foreseeable future is planning to continue promoting Afrezza. The rumors are that the TV ads will start early next year but this is nothing more than a rumor from the representatives. We shall see. Oddly enough this does coincide with a cafepharma post yesterday about Vegas. For what its worth.
|
|